Humate-P
Payments companies reported to CMS as associated with Humate-P. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Humate-P, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Humate-P
These are the largest totals companies reported as associated with Humate-P. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $1,915.00 |
| Angela Weyand | Ann Arbor, MI | Pediatric Hematology-Oncology | $1,915.00 |
| Robert Sidonio | Atlanta, GA | Pediatric Hematology-Oncology | $1,915.00 |
| Eric Grabowski | Boston, MA | Pediatric Hematology-Oncology | $60.42 |
| Mariel Smith | Boston, MA | Pediatric Hematology-Oncology | $60.42 |
| Moises Garcia Rosa | Rio Piedras, PR | Pediatric Hematology-Oncology | $60.15 |
| Leslie Soto Velez | San Juan, PR | Pediatrics | $60.15 |
| Jenny Gober Mcdaniel | Las Vegas, NV | Pediatric Hematology-Oncology | $21.66 |
| Dwight Generoso | Las Vegas, NV | Family | $21.66 |
Prescribed Humate-P?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.